Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medroxyprogesterone for COPD Exacerbation
IRCT20211031052922N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of medroxyprogesterone acetate in chronic obstructive pulmonary disease (COPD), sponsored by Isfahan University of Medical Sciences. Started Aug 2021; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20211031052922N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211031052922N1.